MAIA Biotechnology Inc. (MAIA)
AMEX: MAIA
· Real-Time Price · USD
1.57
0.01 (0.64%)
At close: Aug 15, 2025, 3:59 PM
1.55
-1.27%
After-hours: Aug 15, 2025, 07:08 PM EDT
MAIA Biotechnology Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -5.35M | -4.52M | -3.57M | -2.74M | -8.88M | -8.07M | -6.26M | -4.88M | -4.52M | -4.12M | -5.12M | -3.93M | -3.31M | -3.41M | -2.89M | -5.2M | -3.46M | -1.02M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 802.48K | 371.47K | 693.44K | 455.39K | 413.95K | 349.96K | 1.36M | 570.92K | 618.93K | 537.52K | 488.89K | 532.44K | 584.77K | 713.33K | 614.02K | 778.54K | 777.13K | 553.19K |
Other Working Capital | 239.26K | 410.43K | -106.48K | -26.68K | -780.08K | -280.52K | 525.11K | 1.29M | 702.77K | 110.74K | 971.32K | -892.99K | 281.57K | 221.92K | 277.36K | -3.02K | -95.89K | 141.79K |
Other Non-Cash Items | 322.92K | -825.99K | -1.26M | -1.23M | 5.17M | 4.32M | 955.76K | 176.44K | 221.46K | 143.13K | 1M | 1.6M | 426.74K | 780.45K | -69.03K | 2.85M | 1.87M | -46.55K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 86.22K | 769.5K | 227.08K | -12.83K | -1.39M | -62.11K | 916.78K | 971.1K | 1.12M | 75.58K | 1.12M | -919.11K | 439.6K | 154.8K | 740.5K | 260.38K | -136.7K | 261.57K |
Operating Cash Flow | -4.14M | -4.2M | -3.91M | -3.52M | -4.68M | -3.59M | -3.99M | -3.16M | -2.56M | -3.36M | -2.51M | -4.32M | -2.28M | -2.55M | -1.61M | -1.31M | -951.04K | -253.31K |
Capital Expenditures | -4 | 4.00 | -5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 3.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | 3.92M | 341.05K | -4.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 117K | 4.89M | 2.42M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -132.89K | -33.62K | -134.7K | -276.89K | -641.65K | 125.94K | -1.63M | n/a | -633.28K | -1.24M | -120.23K | 157.7K | 853.02K | n/a | n/a | 7.4K |
Financial Cash Flow | 3.41M | 5.46M | 4.85M | 626.82K | 7.99M | 4.72M | 5.03M | 125.94K | 4.12M | n/a | -192.91K | 10.26M | -120.23K | 2.53M | 1.23M | 5.48M | 4.89M | 2.43M |
Net Cash Flow | -718.77K | 1.26M | 910.51K | -2.89M | 3.31M | 1.12M | 1.05M | -3.04M | 1.56M | -3.36M | -3.11M | 5.91M | -2.14M | -280.83K | -378.21K | 4.17M | 3.94M | 2.18M |
Free Cash Flow | -4.14M | -4.2M | -3.91M | -3.52M | -4.68M | -3.59M | -3.99M | -3.16M | -2.56M | -3.36M | -2.51M | -4.32M | -2.28M | -2.55M | -1.61M | -1.31M | -951.04K | -253.31K |